Tr.ang.ngsund, Sweden

Bengt ANGke Sparf

This inventor holds 1 USPTO granted patent. Top assignee: Pharmacia Ab. Active years: 1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bengt ANGke Sparf. Retrieved from https://idiyas.com/inventor/bengt-angke-sparf

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Bengt ANGke Sparf: Innovator in Pharmaceutical Chemistry

Introduction

Bengt ANGke Sparf is a notable inventor based in Trångsund, Sweden. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that address acetylcholine-mediated disorders.

Latest Patents

Sparf holds a patent for a compound known as 3,3-diphenylpropylamines, which includes its use and preparation. This compound is represented by the formula I, or its physiologically acceptable acid salt. The compound is particularly useful in treating conditions such as urinary incontinence, showcasing its potential impact on healthcare.

Career Highlights

Bengt ANGke Sparf has been associated with Pharmacia AB, a company known for its innovative pharmaceutical products. His work has led to advancements in the treatment of various medical conditions, emphasizing his role as a key figure in the industry.

Collaborations

Throughout his career, Sparf has collaborated with notable colleagues, including Rolf A Johansson and Pinchas Moses. These partnerships have contributed to the development of his patented innovations.

Conclusion

Bengt ANGke Sparf's contributions to pharmaceutical chemistry, particularly through his patent on 3,3-diphenylpropylamines, highlight his importance in the field. His work continues to influence the treatment of acetylcholine-mediated disorders, making a significant impact on healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…